Strategic Advocates’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.2K Sell
791
-306
-28% -$4.25K 0.04% 162
2026
Q2
$11.9K Sell
1,097
-1,415
-56% -$15.1K 0.05% 150
2026
Q1
$27.9K Sell
2,512
-55,244
-96% -$703K 0.12% 112
2025
Q4
$963K Sell
57,756
-727
-1% -$11.3K 0.25% 53
2025
Q3
$783K Buy
58,483
+1,446
+3% +$17.1K 0.2% 59
2025
Q2
$730K Sell
57,037
-3,154
-5% -$37.8K 0.22% 66
2025
Q1
$620K Sell
60,191
-46,642
-44% -$600K 0.22% 62
2024
Q4
$1.36M Buy
106,833
+27,612
+35% +$365K 0.46% 35
2024
Q3
$1.01M Buy
79,221
+67,658
+585% +$828K 0.36% 40
2024
Q2
$147K Buy
+11,563
New +$200K 0.06% 118

Other funds holding PATH

Strategic Advocates's PATH Position: Q3 2026 in Review

Strategic Advocates reduced its UiPath (PATH) stake by 28% in Q3 2026, selling an estimated $4.25K and leaving 791 shares worth $10.2K. The position accounts for 0.04% of the portfolio, ranked #162.

Strategic Advocates first reported a position in PATH in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.36M in Q4 2024. 326 funds tracked by Wall St. Rank hold PATH as of Q3 2026.

  • Strategic Advocates held 791 shares of UiPath worth $10.2K as of Q3 2026.
  • Strategic Advocates sold 306 UiPath shares in Q3 2026, an estimated $4.25K.
  • UiPath made up 0.04% of Strategic Advocates's portfolio in Q3 2026, its #162 holding.
  • Strategic Advocates first reported a position in UiPath in Q2 2024 and has held it in 10 quarters since.
  • Strategic Advocates's UiPath position peaked at $1.36M in Q4 2024.
  • 326 funds tracked by Wall St. Rank held UiPath as of Q3 2026.

Based on Strategic Advocates's 13F filing for Q3 2026, filed 3 Nov 2026.